Chinese maker of test-and-measurement instruments, notably oscilloscopes, spectrum and signal analyzers.
Chinese maker of test-and-measurement instruments, notably oscilloscopes, spectrum and signal analyzers.
Sells instruments through distributors worldwide, with a large share of sales overseas, mostly priced below the established test-equipment makers, with the cost edge of Chinese engineering and manufacturing. Revenue follows electronics R&D and education budgets as well as production-line spending.
In one line: A China-based Keysight/Rigol peer.
Moat: narrow (brand, distribution). Established global brand among engineers and hobbyists competing on price/performance.
Headquarters: Shenzhen, China · Employees: 577
Size Siglent Technologies (688112.SS) is a China Industrials company (Miscellaneous Commercial Services) with a market value of $1.19B, the 1854th largest of 4,790 China companies the cockpit tracks. Shares closed at CN¥49.91 on 18 Nov 2026.
Performance Over six months the shares fell 26.4%, against -18.7% for the median peer and -20.0% for the China market (cap-weighted) — 8th lowest of 21 in its peer set.
Growth Revenue grew 29.5% over the last twelve months (peer median +8.6%); the operating margin is 24.1% (peer median 10.5%).
Valuation It trades at 39.2× forward earnings against a peer median of 20.7× (5th most expensive of 17).
Price implies For today's price to make sense, revenue must grow about 28% a year for seven years (Req g). Recent delivered growth is +22%, so the hurdle is +6 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
Capital Return on invested capital runs 21.8 points above its cost of capital (10.7% WACC).
Next results Next results expected around 29 Apr 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | CN¥744M | CN¥598M | CN¥495M | CN¥480M | CN¥396M |
| Revenue growth | — | +21% | +3% | +21% | — |
| Gross profit | CN¥473M | CN¥351M | CN¥291M | CN¥286M | CN¥224M |
| EBITDA | n/a | CN¥135M | CN¥98.5M | CN¥126M | CN¥100M |
| Net income | CN¥185M | CN¥143M | CN¥112M | CN¥155M | CN¥141M |
| Free cash flow | CN¥109M | CN¥152M | CN¥83.8M | CN¥86.5M | CN¥13.3M |
| Capital expenditure | CN¥30.9M | CN¥28.7M | CN¥34.3M | CN¥21.2M | CN¥16.4M |
| Total debt | CN¥30.5M | CN¥36.5M | CN¥44.3M | CN¥15.0M | CN¥21.5M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 688112.SS | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -36.0% | -2.3% | lowest of 21 |
| 6-month return | -26.4% | -18.7% | 8th lowest of 21 |
| Distance from 52-week high | -59.1% | -37.5% | 2nd lowest of 21 |
| Revenue growth (TTM) | +29.5% | +8.6% | 2nd highest of 21 |
| Operating margin | 24.1% | 10.5% | 2nd highest of 21 |
| Forward P/E | 39.2× | 20.7× | 5th most expensive of 17 |
| Growth the price implies (Req g, 7 yrs) | 27.7% | 8.9% | 4th most demanding of 16 |
| Growth delivered (Del g) | +22.0% | +11.7% | 4th highest of 15 |
| Hurdle (Req g minus delivered) | +5.7 pp | -11.0 pp | 5th most demanding of 15 |
| ROIC minus cost of capital | +21.8 pp | +1.5 pp | highest of 21 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Siglent Technologies 688112.SS | China | $1.19B | -26% | +30% | 24% | 39.2× | 27.7% | +22.0% |
| Shanxi Huaxiang 603112.SS | China | $1.19B | -33% | +9% | 11% | 11.6× | 0.9% | +16.2% |
| Nittetsu Mining 1515.T | Japan | $1.17B | -3% | +18% | 8% | n/a | n/a | n/a |
| Resolute Holdings Management RHLD | United States | $1.16B | +34% | +10% | 12% | n/a | 16.6% | n/a |
| Jadard Technology 688252.SS | China | $1.14B | -22% | +6% | 12% | 22.3× | 12.0% | +31.3% |
| Concord Biotech CONCORDBIO.NS | India | $1.26B | -2% | +4% | 28% | 33.9× | 44.4% | +11.6% |
| Suzhou Recodeal Interconnect System 688800.SS | China | $1.26B | -68% | +5% | 9% | 31.0× | 22.7% | +38.9% |
| Willdan WLDN | United States | $1.13B | -20% | +19% | 7% | 14.6× | 17.2% | +11.8% |
| Suzhou Novoprotein Scientific 688137.SS | China | $1.12B | +117% | +8% | -62% | n/a | n/a | n/a |
| Vcanbio Cell & Gene Engineering 600645.SS | China | $1.11B | -29% | -6% | 12% | 40.7× | 8.9% | +1.9% |
| FESCO 600861.SS | China | $1.10B | -15% | +4% | 1% | 10.5× | n/a | n/a |
| China East Education 0667.HK | Hong Kong | $1.09B | -21% | +16% | 22% | 7.8× | -7.5% | +4.1% |
| Shanghai MicroPort EP Medtech 688351.SS | China | $1.31B | -30% | +20% | 3% | 137.1× | 42.5% | +26.7% |
| TKC 9746.T | Japan | $1.31B | +22% | +5% | 20% | 19.1× | -10.1% | +5.7% |
| Prosegur Cash CASH.MC | Spain | $1.07B | +10% | -2% | 11% | 9.6× | -12.1% | +5.7% |
| Changchun Up Optotech 002338.SZ | China | $1.34B | -41% | +22% | 2% | 43.1× | n/a | n/a |
| China Security 600654.SS | China | $1.34B | -31% | -30% | -1% | n/a | 56.0% | +0.4% |
| SBT Ultrasonic Technology 688392.SS | China | $1.06B | -36% | +42% | 17% | 49.3× | n/a | n/a |
| China National Electric Apparatus Research Institute 688128.SS | China | $1.35B | -17% | +8% | 11% | 14.7× | 3.2% | +13.5% |
| SBS 2384.T | Japan | $1.35B | +26% | +17% | 5% | 13.9× | -4.7% | +13.8% |
| CRA International CRAI | United States | $1.35B | +46% | +13% | 10% | 23.3× | 6.6% | +8.1% |